Advances in the use of drug-coated balloons in coronary interventions
Liu Zhengrong
Zhao Zhenyan
Wu Yongjian
Abstract：Although drug-eluting stents have become the standard approach of percutaneous coronary intervention,the risk of late stent thrombosis and in-stent restenosis remains.Drug-coated balloons(DCBs),which directly deliver anti-proliferative drugs through transient expansion.have shown great clinical potential due to their"no implantation"concept,avoiding the long-term risks associated with permanent implants.This article reviews the use of DCB in patients with in-stent restenosis,de novo coronary artery lesions,complex coronary artery lesions,high bleeding risk,diabetes mellitus,and acute coronary syndromes.DCB not only shows the same or even better efficacy and safety than DES in specific clinical scenarios,but also provides a new direction for coronary intervention therapy in its unique indications.In the future,DCB is expected to promote the transformation of the treatment mode of coronary heart disease through wider clinical application and in-depth research,to improve the prognosis of patients,and to become an important innovation in the field of coronary intervention.
Keywords：Coronary artery diseasePercutaneous coronary interventionDrug-coated balloonDrug-eluting stentDe novo coronary artery lesions
Publication Date：2024-08-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 1-6 )